Kolexia
Duron Cedric Gastro-entérologie
Duron Cedric
Gastro-entérologie
Centre Hospitalier de Montlucon
Montluçon, France
36 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Fibrose Thrombophilie Cirrhose du foie Déficit en protéine C Maladie de Crohn Toxidermies Résistance à la protéine C activée Maladies vasculaires Maladies inflammatoires intestinales

Collaborateurs

Voir plus
Lebreton Aurelien
Lebreton Aurelien
Hôpital Estaing, Clermont-Ferrand, France
Sinegre Thomas
Sinegre Thomas
Hôpital Gabriel Montpied, Clermont-Ferrand, France
Lamblin Géraldine
Lamblin Géraldine
Hôpital Estaing, Clermont-Ferrand, France
Buisson Anthony
Buisson Anthony
Hôpital Estaing, Clermont-Ferrand, France

Industries

Voir plus
Takeda Pharmaceutical
2 collaboration(s)
Dernière en 2023
Pfizer
2 collaboration(s)
Dernière en 2022
Abbvie
1 collaboration(s)
Dernière en 2020
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Intraindividual variability over time of thrombin generation in patients with cirrhosis.
Journal of thrombosis and haemostasis : JTH   08 février 2023
Deeper: STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP
Essai Clinique (CHU Clermont-Ferrand)   19 avril 2022
Extrahepatic portal vein obstruction (EHPVO) in cirrhosis.
Clinics and research in hepatology and gastroenterology   17 avril 2020
Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis.
Journal of thrombosis and haemostasis : JTH   17 mai 2018
Plasma hypercoagulability in the presence of thrombomodulin but not of activated protein C in patients with cirrhosis.
Journal of gastroenterology and hepatology   22 septembre 2017
Low sensibility to the action of thrombomodulin in cirrhotic patients. Interest of thrombinography.
Annales de biologie clinique   09 janvier 2017
Acquired protein C deficiency: a major factor in the hypercoagulable state in patients with cirrhosis.
The 67th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2016   01 octobre 2016
Factors influencing acute infusion reactions in inflammatory bowel disease patients treated with infliximab in the era of scheduled maintenance therapy.
European journal of gastroenterology & hepatology   22 février 2016
Hypercoagulability in Cirrhotic Patients; Impact of Acquired Protein C Deficiency and Factor VIII Increase in Low Sensitivity to Thrombomodulin
Blood   01 janvier 2016
Soluble Endothelial Protein C Receptor (sEPCR) Is Increased in Cirrhotic Patients. A Possible Role in Procoagulant Imbalance?
Blood   03 décembre 2015